| Document Date: 2009-03-31 14:50:50
Open Document File Size: 377,25 KBShare Result on Facebook
Country United States / / Currency pence / / Event Product Issues / / IndustryTerm active site / cola beverage / sterilized organ systems / methanolic solutions / imaging / / MedicalCondition CONTRAINDICATIONS Congestive Heart Failure / esophageal candidiasis / congestive heart failure / ventricular tachycardia / uremia / chronic cavitary pulmonary disease / ventricular dysfunction / torsades de pointes / disease / tinea unguium / Capsules Congestive Heart Failure / Histoplasmosis / disseminated disease / non-meningeal histoplasmosis / onychomycosis / Renal Insufficiency / disseminated fungal infections / residual nail deformity / Aspergillosis / AIDS / hypersensitivity / infection / cardiac arrest / Blastomycosis / infections / fungal infections / Hepatic Insufficiency / absolute achlorhydria / / MedicalTreatment continuous ambulatory peritoneal dialysis / hemodialysis / antifungal therapy / intravenous infusion / / Organization Concomitant administration / US Federal Reserve / / Product SPORANOX / itraconazole / ranitidine / amphotericin B / simvastatin / polyethylene glycol / ketoconazole / triazolam / lovastatin / hepatic function / / Technology Pharmacokinetics / dialysis / /
SocialTag |
SPORANOX® (itraconazole) Capsules Congestive Heart Failure: SPORANOX® (itraconazole) Capsules should not be administered for the treatment of onychomycosis in patients with evidence of ventricular